Research

  • Ground-breaking ‘earbud’ test for Alzheimer’s and Parkinson’s

    A ground-breaking at-home 'earbud' test could pave the way for the early detection, diagnosis, prevention and treatment of serious brain diseases. Researchers are developing and testing a novel electroencephalogram (EEG) system similar to a pair of in-ear headphones that maps brain activity during sleep and could help diagnose neurodegenerative diseases such as Alzheimer's and Parkinson's [...]

  • Parkinson’s disease therapy pipeline offers promising new treatment hope

    It was in 1817 that Parkinson’s disease was first described as a neurological disorder. In a detailed medical essay written by the London-based doctor who was to go on and give his name to the progressive disease, James Parkinson, he talked about the ‘shaking palsy’. More than 200 years on, and whilst scientists have made [...]

  • Gene involved in heart attacks discovered

    A gene that plays a vital role in determining people’s susceptibility to a range of potentially fatal vascular conditions, such as heart attacks, has been pinpointed. The discovery advances understanding of the underlying causes of a wide range of serious health conditions, including hardening of the arteries, and, say researchers from the University of Virginia’s [...]

  • Talking therapies could cut risk of heart disease

    Using talking therapies to help deal with depression may cut the risk of suffering a heart attack or stroke in later life, a new University College London study suggests. Previous research has advocated that those affected by depression and anxiety are more likely to suffer from cardiovascular problems. Now this latest study published in the [...]

  • Groundbreaking new approach to Alzheimer’s diagnosis and treatment

    South Korean scientists have made a potentially groundbreaking discovery that could change how Alzheimer’s disease is diagnosed and treated. The team from the Center for Cognition and Sociality within the Institute for Basic Science in Daejeon in central west South Korea, have discovered that reactive astrocytes rather than amyloid-beta plaques, may be the cause of [...]

  • Have scientists finally found the cure for ageing?

    Cleopatra is said to have favoured asses’ milk, the ancient Greeks olive oil and yoghurt, Elizabethan women slices of raw meat, the Georgians mature wine, and the Victorians honey, oatmeal and egg yolks. The above may read like a catalogue of fashionable foods from an historical grocery list or the latest fad diet. But in [...]

  • Hearing aids could help cut risk of dementia

    Adults suffering hearing loss could cut their risk of developing dementia by wearing a hearing aid, a new decade-long study suggests. An international team of scientists compared outcomes by tracking 437,704 people with varying degrees of hearing impairment, whose data is stored in the UK biobank, a large-scale biomedical database and research resource containing in-depth [...]

  • Novel stroke treatment receives new US patent

    A new twist on a drug used to treat alcohol use disorder could double up as a treatment for stroke. Carb - short for Carbamathione - is a new formulation designed to treat ischemic stroke, protect brain tissue against injury and minimise the size of localised brain damage. About 87% of all strokes are caused [...]

  • High blood pressure in 30s linked to later life dementia risk

    Treating high blood pressure in young and middle-aged adults could help prevent later life dementia and Alzheimer’s, a new study suggests. Research published by UC Davis in JAMA Network Open, a monthly open access medical journal produced by the American Medical Association, reveals that hypertension in your 30s is associated with worse brain health around [...]

  • Biotech firm secures £1.85m to help save thousands of prostate cancer lives

    A seven-figure funding boost to further develop a prostate cancer test could help save thousands of lives, its developers say. Despite being the most common malignancy other than skin cancer diagnosed in men, prostate cancer survival rates have improved little in the past four decades.  But UK-based biotech firm Nanovery is hoping to turn the [...]